{"schema_version":"secwatch.filing_event.v1","accession":"0000105770-21-000080","form_type":"8-K","ticker":"WST","cik":"0000105770","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2021-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.305681+00:00","generated_at":"2026-06-28T16:32:01.708235+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"West Pharma Q3 net sales $706.5M (+28.9%); adj. EPS $2.06 (+79%); raises FY guidance, dividend up 5.9%","bullets":["Net sales of $706.5M grew 28.9% (organic +27.9%); reported diluted EPS $2.31 (+112%).","Adjusted diluted EPS of $2.06 increased 79% YoY.","Proprietary Products segment sales grew 36.9% to $577M; HVP portfolio led growth.","Full-year 2021 net sales guidance raised to $2.800-$2.810B; adj. EPS to $8.40-$8.50.","Quarterly dividend increased 5.9% to $0.18/share, payable Nov 17, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-21-000080","json":"https://secwatch.observer/filing/0000105770-21-000080.json","markdown":"https://secwatch.observer/filing/0000105770-21-000080.md","text":"https://secwatch.observer/filing/0000105770-21-000080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577021000080/0000105770-21-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577021000080/wst-20211028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:32:01.708235+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}